Details of the Drug

General Information of Drug (ID: DMHUCQQ)

Drug Name
Reviroc
Synonyms TH-9401; Antileukemics (photoactive), Theratechnologies; Tumor cell depletion therapy (hematological cancers), Kiadis
Indication
Disease Entry ICD 11 Status REF
B-cell lymphoma 2A86 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C21H15Br2ClN2O3
Canonical SMILES
COC(=O)C1=CC=CC=C1C2=C3C=CC(=N)C(=C3OC4=C2C=CC(=C4Br)N)Br.Cl
InChI
InChI=1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H
InChIKey
MUDCDMMNYVJLEB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9871944
CAS Number
174230-05-8
TTD ID
D0M1MZ

References

1 ClinicalTrials.gov (NCT02519816) Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD.